Investor Relations
Board of Directors
Biographies of the Bausch + Lomb Board of Directors:
Fred Hassan, Chairman
Fred Hassan is the chairman of Bausch + Lomb. He was elected to this role in March 2010.
Mr. Hassan is the former chairman and chief executive officer of Schering-Plough Corporation. He serves currently on the boards of Avon and Time-Warner, and is a senior advisor with the private equity firm Warburg Pincus.
Hassan was chairman and chief executive officer of Schering-Plough Corporation from 2003 until its merger with Merck & Co. in November 2009. He previously served as chief executive officer and as chairman and chief executive officer of Pharmacia Corporation from 2001 to 2003 until its acquisition by Pfizer Inc. Mr. Hassan is also the former chief executive officer of Pharmacia and Upjohn Inc., which merged with the Monsanto Corporation to become Pharmacia Corporation in 2000.
He is a member of The Business Council, and is the past chairman of the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA).
He holds a bachelor’s of science degree from the Imperial College of Science and Technology at the University of London and an M.B.A. degree from Harvard Business School.
Brent L. Saunders, Chief Executive Officer
Brent Saunders is chief executive officer of Bausch + Lomb. He was appointed to this position in March 2010.
Mr. Saunders brings significant expertise in the pharmaceutical industry, having recently served as a senior executive with Schering-Plough. Most recently he held the position of president of Global Consumer Health Care and was named head of integration for Schering-Plough's merger with Merck & Co. and for Schering-Plough's acquisition of Organon BioSciences.
Before joining Schering-Plough, Mr. Saunders was a partner and head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was chief risk officer at Coventry Health Care and senior vice president, Compliance, Legal and Regulatory at Home Care Corporation of America. Mr. Saunders began his career as chief compliance officer for the Thomas Jefferson University Health System.
Mr. Saunders serves on the Board of Directors of ElectroCore LLC and the Overlook Hospital Foundation. He is chairman of the Board of Directors of the American Heart Association.
Mr. Saunders, 40, earned his MBA from Temple University School of Business, his J.D. from Temple University School of Law and his bachelor's degree from the University of Pittsburgh.
Sean D. Carney, Managing Director, Warburg Pincus
Mr. Carney joined Warburg Pincus in 1996 and focuses on investments in medical devices. Prior to joining Warburg Pincus, he was a consultant with McKinsey & Company. Mr. Carney is a director of Aeolus, Arch Capital Group, DexCom, Keystone Dental, NuLens and Tornier. He received an A.B. degree in economics from Harvard College and an M.B.A. from Harvard Business School.
R. Kerry Clark
Mr. Clark retired in September 2009 as chairman and chief executive officer of Cardinal Health, Inc. Before his leadership at Cardinal Health, Mr. Clark spent more than 30 years at Procter & Gamble Co., where he last served as vice chairman of the board. Mr. Clark is currently director of Textron, General Mills and Hauser Capital Partners. He holds a bachelor’s degree from Queens University.
Joseph P. Landy, Co-President, Warburg Pincus
Mr. Landy joined Warburg Pincus in 1985 and focuses on investments in information technology, communications applications and structured investments. A former president of the Venture Investors Association of New York, Mr. Landy is a trustee of the Clark Art Institute and of the Williamstown Art Conservation Center. He is a director of The Cobalt Group, Telcordia Technologies, RMI Corporation and MicroVest, an investment fund focused on microfinance institutions in developing countries. He holds a B.S. degree in economics from The Wharton School at the University of Pennsylvania and an M.B.A. from the Leonard N. Stern School of Business at New York University.
D. Scott Mackesy, Welsh, Carson, Anderson & Stowe
Mr. Mackesy joined Welsh, Carson, Anderson & Stowe (WCAS) in 1998. He is a general partner focusing on investments in the healthcare industry and is a member of the WCAS Management Committee. Prior, Mr. Mackesy was a senior research analyst at Morgan Stanley Dean Witter, where he was responsible for coverage of the healthcare services sector. Mr. Mackesy serves on the boards of directors of several private companies including Ardent Health Services L.L.C., Renal Advantage, Inc., and United Surgical Partners, Inc.
Robert J. Palmisano, President, Chief Executive Officer, ev3 Inc.
Mr. Palmisano is president, chief executive officer and director of ev3 Inc., a global provider of technology for treating peripheral vascular disease and neurovascular diseases. Prior to ev3 Inc., Mr. Palmisano was president and chief executive officer for IntraLase Corp. which was later acquired by Advanced Medical Optics Inc. Mr. Palmisano has also served as president and chief executive officer for pharmaceuticals firm MacroChem Corporation and Summit Autonomous, Inc., a global medical products company later acquired by Alcon. Mr. Palmisano has a long history with Bausch & Lomb, holding various executive positions within the company from 1985 to 1996. His last role with Bausch & Lomb was as senior vice president and president of its eyewear division. He holds a bachelor’s degree from Providence College.
Richard F. Wallman
Mr. Wallman was senior vice president and chief financial officer of Honeywell International, Inc. from 1995 until his retirement in 2003. Prior, he was vice president and controller at IBM Corporation, and held leadership positions at Chrysler Corporation over the course of 14 years. He is a director of Ariba, Convergys, Hayes Lemmerz International, Lear Corporation, and Roper Industries. Mr. Wallman holds a B.S. degree in electrical engineering from Vanderbilt University and an M.B.A. from the University of Chicago.
Elizabeth H. Weatherman, Managing Director, Warburg Pincus
Ms. Weatherman joined Warburg Pincus in 1988 and is responsible for the firm's medical device investment activities. Ms. Weatherman is a director of Bacchus Vascular, ev3 and Tornier. She also serves on the board of the National Venture Capital Association. Ms. Weatherman received a B.A. degree, summa cum laude, from Mount Holyoke College and an M.B.A. from the Stanford Graduate School of Business.
